Medexus Pharmaceuticals Inc.

Medexus Pharmaceuticals Inc.verified

MEDXF

Price:

$1.93

Market Cap:

$61.97M

Medexus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada and the United States. It focuses on the therapeutic areas comprising oncology, hematology, rheumatology, auto-immune diseases, and allergy. The company's primary products are Rasuvo and Metoject, a formulation of methotrexate designed to treat rheumatoid arthritis and other auto-immune diseases; IXINITY, an intravenous recombinant factor IX therapeutic for use in patients 12 years of age or older with Hemophilia B; and Rupall, a prescription allergy medication. Its products portfolio also includes Treosulfan, a bifunctional alkylating agent for allogeneic hematopoietic stem cell transplantation; Trispan, a...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2017-11-27

Stock Exchange

OTC

Ticker

MEDXF

The Enterprise Value as of December 2025 (TTM) for Medexus Pharmaceuticals Inc. (MEDXF) is 74.53M

According to Medexus Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 74.53M. This represents a change of -26.96% compared to the average of 102.05M of the last 4 quarters.

Medexus Pharmaceuticals Inc. (MEDXF) Historical Enterprise Value (quarterly & annually)

How has MEDXF Enterprise Value performed in the past?

The mean historical Enterprise Value of Medexus Pharmaceuticals Inc. over the last ten years is 68.26M. The current 74.53M Enterprise Value has changed 10.82% with respect to the historical average. Over the past ten years (40 quarters), MEDXF's Enterprise Value was at its highest in in the June 2021 quarter at 195.95M. The Enterprise Value was at its lowest in in the June 2016 quarter at 9.45M.

Quarterly (TTM)
Annual

Average

68.26M

Median

72.59M

Minimum

12.00M

Maximum

152.95M

Medexus Pharmaceuticals Inc. (MEDXF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Medexus Pharmaceuticals Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 120.14%

Maximum Annual Enterprise Value = 152.95M

Minimum Annual Increase = -43.64%

Minimum Annual Enterprise Value = 12.00M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202575.69M-6.06%
202480.58M-26.09%
2023109.02M5.41%
2022103.42M-32.38%
2021152.95M120.14%
202069.48M118.72%
201931.76M19.44%
201826.59M25.74%
201721.15M76.28%
201612.00M-43.64%

Medexus Pharmaceuticals Inc. (MEDXF) Average Enterprise Value

How has MEDXF Enterprise Value performed in the past?

The current Enterprise Value of Medexus Pharmaceuticals Inc. (MEDXF) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

88.43M

5-year avg

104.33M

10-year avg

68.26M

Medexus Pharmaceuticals Inc. (MEDXF) Enterprise Value vs. Peers

How is MEDXF’s Enterprise Value compared to its peers?

Medexus Pharmaceuticals Inc.’s Enterprise Value is less than Planet 13 Holdings Inc. (98.19M), less than Decibel Cannabis Company Inc. (101.15M), greater than Earth Science Tech, Inc. (39.07M), less than Flower One Holdings Inc. (88.59M), greater than TransCanna Holdings Inc. (19.70M), less than Precision System Science Co., Ltd. (4.61B), greater than 1CM Inc. (19.37M), greater than International Isotopes Inc. (34.79M), greater than Vext Science, Inc. (71.67M), greater than Nicox S.A. (31.80M),

Build a custom stock screener for Medexus Pharmaceuticals Inc. (MEDXF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Medexus Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Medexus Pharmaceuticals Inc. (MEDXF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Medexus Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Medexus Pharmaceuticals Inc.'s Enterprise Value?

What is the highest Enterprise Value for Medexus Pharmaceuticals Inc. (MEDXF)?

What is the 3-year average Enterprise Value for Medexus Pharmaceuticals Inc. (MEDXF)?

What is the 5-year average Enterprise Value for Medexus Pharmaceuticals Inc. (MEDXF)?

How does the current Enterprise Value for Medexus Pharmaceuticals Inc. (MEDXF) compare to its historical average?